Description

Febuxostat is a new non-purine selective xanthine oxidase (XO) inhibitor, which is an effective substitute for allopurinol allergic or gout intolerant patients, especially for patients with renal insufficiency. The appearance of the product is white powder, good stability, high content, for the company’s long-term production of drugs.